Drugdiscovery >> Clinical Trials >> News
7715
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial - drugdiscovery.com
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial - drugdiscovery.com


The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sugar levels compared to either of the two drugs alone in adults with type 2 diabetes.
Read More >>


Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination - September 28, 2013
Related Articles
6588
Views
Trajenta successful  in Phase III trial in elderly Type 2 diabetes patients Trajenta successful in Phase III trial in elderly Type 2 diabetes patients
Trajenta (linagliptin), marketed by Eli Lilly and Boehringer Ingelheim, showed safe and effective in Phase III trial, significantly reducing the blood glucose levels in elderly people with Type 2 diab Read More >>

Tags: Trajenta, type 2 diabetes, elderly, blood glucose control

3041
Views
BMS diabetes drug successful in late-stage study BMS diabetes drug successful in late-stage study
Bristol-Myers Squibb has announced that its diabetes drug dapagliflozin, helped improve blood sugar levels and reduce body weight in patients with type 2 diabetes who were taking a combination of metf Read More >>

Tags: type 2 diabetes, Bristol-Myers Squibb, dapagliflozin, clinical trial, Forxiga

5177
Views
Tresiba efficient in type 2 diabetes patients - study shows Tresiba efficient in type 2 diabetes patients - study shows
The results of the study demonstrate that Novo Nordisk’s recently launched drug Tresiba (insulin degludec) enables patients with type 2 diabetes to sustain good long-term glycemic control, when used Read More >>

Tags: Tresiba, glycemic control, type 2 diabetes, Novo Nordisk, insulin degludec

5923
Views
Afrezza inhaled insulin successful in Phase III trials Afrezza inhaled insulin successful in Phase III trials
MannKind’s inhaled insulin Afrezza showed clearly positive results in Phase III studies on Type 1 and Type 2 diabetes. The new drug application will be submitted to the FDA early in the fourth qua Read More >>

Tags: MannKind, inhaled insulin, Afrezza, clinical trials,type 1, type 2, diabetes

5448
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

3903
Views
Insulin pill in a new clinical trial for type 1 diabetes Insulin pill in a new clinical trial for type 1 diabetes
Oramed Pharmaceuticals has initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule also known as ORMD-0801, for patients with type 1 diabetes in Israel. Read More >>

Tags: insulin, pill, orally ingestible, insulin capsules, oramed, clinical trial, type 1 diabetes

8501
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

8398
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

34020
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

4331
Views
The results of linagliptin safety trials in patients with type 2 diabetes The results of linagliptin safety trials in patients with type 2 diabetes
Eli Lilly and Boehringer Ingelheim presented the results from two pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the linagliptin in adults with type 2 di Read More >>

Tags: lingliptin, type 2 diabetes, safety, clinical trials, Eli Lilly

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013